2009
DOI: 10.1111/j.1365-2559.2008.03191.x
|View full text |Cite
|
Sign up to set email alerts
|

Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma

Abstract: Membranous/cytoplasmic Ki67 identifies a group of breast carcinomas that may be important to consider separately in prognostic and predictive studies. The mechanism of subcellular Ki67 relocalization remains elusive and further studies are required to establish both the cause and effect of this unusual pattern of Ki67 immunoreactivity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
58
5
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 60 publications
(72 citation statements)
references
References 12 publications
8
58
5
1
Order By: Relevance
“…These data are consistent with the findings of Faratian et al (42); however, Boland et al (13) observed the opposite, showing that cases with a high Ki-67 expression positively correlated with negative HR (p=0.003).…”
Section: Discussionsupporting
confidence: 82%
“…These data are consistent with the findings of Faratian et al (42); however, Boland et al (13) observed the opposite, showing that cases with a high Ki-67 expression positively correlated with negative HR (p=0.003).…”
Section: Discussionsupporting
confidence: 82%
“…That Ki-67 is present during all active phases (G 1 , S, G 2 and mitosis) of the cell cycle, but absent in resting cells (G 0 ), makes it an excellent marker for determining the so-called growth fraction of a cell population (Scholzen & Gerdes 2000). Recently, membranous and cytoplasmic Ki-67 expression was described in studies of pathological conditions such as hyalinizing trabecular adenoma of the thyroid, sclerosing hemangioma of the lung, pleomorphic adenoma of the salivary gland, and in invasive ductal carcinomas of the breast (Hirokawa & Carney 2000;Hattori 2002;Tashiro et al 2002;Faratian et al 2009). While a relationship between membranous/cytoplasmic Ki-67 expression with other proteins has been noted (Faratian et al 2009), the mechanism of subcellular Ki-67 relocalization remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, membranous and cytoplasmic Ki-67 expression was described in studies of pathological conditions such as hyalinizing trabecular adenoma of the thyroid, sclerosing hemangioma of the lung, pleomorphic adenoma of the salivary gland, and in invasive ductal carcinomas of the breast (Hirokawa & Carney 2000;Hattori 2002;Tashiro et al 2002;Faratian et al 2009). While a relationship between membranous/cytoplasmic Ki-67 expression with other proteins has been noted (Faratian et al 2009), the mechanism of subcellular Ki-67 relocalization remains unclear. To date, mutations in the Ki-67 gene have not been described in order to explain an abnormal protein product with altered localization properties (Faratian et al 2009).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, immunostaining for MIB-1 has been generally used in diagnosing HTT. Of note, the aberrant staining pattern is also observed in breast carcinoma [9], salivary gland pleomorphic adenoma [10], and pulmonary sclerosing hemangiomas [11], but no diagnostic significance has been demonstrated. Leonardo et al described that crossreactivity of MIB-1 monoclonal antibody with a cell membrane epitope seems the most likely explanation for the findings [8].…”
Section: Discussionmentioning
confidence: 99%